Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus
Data up to Jan 2025
Total Citations Per Year
Abstract
References (49)
Pathogenesis of Foreign Body Infection: Description and Characteristics of an Animal Model
1982 • 610 citations
Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis
1991 • 587 citations
Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response
1990 • 405 citations
Correlation between In Vivo and In Vitro Efficacy of Antimicrobial Agents against Foreign Body Infections
1990 • 314 citations
Clinical Pharmacokinetics of Teicoplanin
1990 • 253 citations
Resistance to vancomycin and teicoplanin: an emerging clinical problem
1990 • 235 citations
Antibiotic Tolerance Among Clinical Isolates of Bacteria
1985 • 208 citations
Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus Endocarditis
1990 • 170 citations
Staphylococcus aureus Endocarditis
1978 • 159 citations
Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations
1991 • 142 citations
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus
1990 • 138 citations
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance
1992 • 134 citations
Early Termination of a Prospective, Randomized Trial Comparing Teicoplanin and Flucloxacillin for Treating Severe Staphylococcal Infections
1987 • 132 citations
Resistance of Staphylococcus aureus Recovered from Infected Foreign Body In Vivo to Killing by Antimicrobials
1991 • 119 citations
Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon
1991 • 112 citations
Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus aureus with Vancomycin and Rifampin
1983 • 111 citations
Efficacy of Vancomycin Plus Rifampin in Experimental Aortic-Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: In Vitro-in Vivo Correlations
1985 • 102 citations
Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents
1985 • 101 citations
Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis
1990 • 98 citations
Microbiological properties of teicoplanin
1988 • 95 citations
Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin
1991 • 90 citations
Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin
1990 • 87 citations
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria
1986 • 86 citations
Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters
1989 • 81 citations
A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria
1988 • 79 citations
Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients
1989 • 79 citations
Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics
1993 • 76 citations
A review of the safety profile of teicoplanin
1991 • 74 citations
Clinical Study of Combination Therapy with Oxacillin and Rifampin for Staphylococcal Infections
1983 • 69 citations
Teicoplanin
1984 • 66 citations
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients
1987 • 65 citations
Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts
1991 • 63 citations
Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis
1990 • 63 citations
Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection
1990 • 60 citations
Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections
1987 • 60 citations
Dosage recommendations for teicoplanin
1993 • 57 citations
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus
1984 • 54 citations
Teicoplanin in the treatment of gram-positive-bacterial endocarditis
1989 • 51 citations
Clinical efficacy and safety of teicoplanin
1988 • 44 citations
Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results
1988 • 43 citations
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus
1984 • 36 citations
Teicoplanin Compared with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis
1986 • 28 citations
Teicoplanin monotherapy of serious infections caused by Gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial
1991 • 28 citations
Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus
1994 • 25 citations
Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin
1990 • 23 citations
Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with teicoplanin
1986 • 21 citations
Clinical efficacy of teicoplanin
1990 • 18 citations
Activity of teicoplanin in localized experimental infections in rats
1986 • 12 citations
Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus
1987 • 11 citations